查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1370915

肠内餵食配方奶粉市场- 2018-2028年全球产业规模、份额、趋势、机会和预测，按产品、按流程类型、按阶段、按适应症、按最终用途、按地区、按竞争细分

Enteral Feeding Formulas Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product, By Flow Type, By Stage, By Indication, By End-Use, By Region, By Competition
出版日期: | 出版商: TechSci Research | 英文 177 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2022年，全球肠内餵食配方奶粉市场估值达到58.9亿美元，预计在预测期内将稳定成长，预计复合年增长率（CAGR）为6.81%，到2028年预计将达到88.3亿美元。全球医疗保健产业正在经历重大转型，人们越来越重视全面的病患照护。营养是患者健康的重要方面，对于因健康状况而无法口服食物的个体来说，肠内餵食配方奶粉已成为重要的解决方案。全球肠内餵食配方奶粉市场在确保从早产儿到老年患者的个人获得恢復和整体健康所需的重要营养方面发挥着关键作用。

肠内餵食涉及透过管子将营养物质直接输送到胃肠道。当个体因吞嚥障碍、消化问题或重症而面临口服食物消耗的挑战时，可以采用这种方法。肠内餵食配方食品，也称为肠内营养或管饲配方食品，是含有大量营养素、维生素和矿物质的均衡混合物的专用液体溶液。这些配方奶粉旨在满足从婴儿到成人的不同患者群体的特定营养需求。它们可以分为多种类型，包括标准配方、针对特定疾病的配方以及针对特定医疗状况（例如糖尿病或肾衰竭）量身定制的特殊配方。

全球人口老化很容易出现各种健康状况，进而影响他们正常饮食的能力。这导致对老年人营养需求量身定制的肠内餵食配方奶粉的需求增加。癌症、神经系统疾病和胃肠道疾病等慢性疾病通常会影响患者食用固体食物的能力。在这种情况下，肠内餵食配方食品提供了提供必需营养素的有效方法。由于配方奶粉成分的进步、针对特定疾病的配方奶粉的开发以及管饲技术的创新，市场不断扩大。这些发展使肠内营养更加可行和有效，从而促进了市场成长。

市场概况
预测期 2024-2028
2022 年市场规模 58.9亿美元
2028 年市场规模 88.3亿美元
2023-2028 年复合年增长率 6.81%
成长最快的细分市场 胃肠道疾病
最大的市场 北美洲

主要市场驱动因素：

  • 1.慢性病盛行率上升：慢性病具有病程长、进展缓慢的特点，已成为全球发病和死亡的主要原因。肠内餵食配方奶粉的需求不断增长，已成为慢性病管理的重要组成部分，推动了全球肠内餵食配方奶粉市场的扩张。生活方式的改变、城市化、人口老化以及烟草使用、不健康饮食、缺乏身体活动和过量饮酒等风险因素导致了慢性病的激增。肠内餵食配方奶粉，也称为管饲配方奶粉，是一种营养产品，旨在为无法口服摄取足够营养的人直接向胃肠道提供必需营养。这些配方透过放置在胃或肠中的管子进行施用，确保个人获得维持健康和福祉所需的营养。
  • 2.人口老化加剧：随着世界人口持续老化，老年人口比例不断增加，全球医疗健康产业面临新的挑战和机会。受这种人口变化影响的关键领域之一是肠内餵食配方市场。肠内餵食涉及直接向消化系统提供营养，这对于老年人的健康至关重要，因为老年人可能因各种健康状况而难以摄取适当的营养。这导致了全球肠内餵食配方奶粉市场的兴起，该行业正在迅速扩张，以满足人口老化的需求。

主要市场挑战：

  • 1.监管障碍：肠内餵食配方奶粉市场面临的主要挑战之一是复杂的监管环境。不同的国家有不同的法规和标准来管理这些产品的生产、标籤和行销。製造商必须应对一系列法规，以确保其产品符合当地法律，同时满足全球品质标准。这不仅增加了营运复杂性，而且还为希望在市场上立足的新进入者设置了障碍。
  • 2.成本限制：肠内餵食配方奶粉通常比普通食品更昂贵，这主要是由于其成分和生产过程的特殊性。费用可能成为患者的重大负担，尤其是需要长期肠内餵食解决方案的患者。此外，随着医疗保健提供者和保险公司寻求具有成本效益的选择，成本限制可能会给製造商带来定价压力。对于製造商和患者来说，在负担能力和品质之间取得平衡成为一个重大挑战。
  • 3.营养定制：需要肠内餵食的患者根据其医疗状况、年龄和整体健康状况有不同的营养需求。开发可自订的配方来满足这些独特的要求是一项挑战。製造商需要投资研发，创造出不仅营养均衡而且可以针对个别患者量身订製的产品。在保持生产效率和成本效益的同时实现这种程度的客製化可能是一种微妙的平衡行为。
  • 4.意识和教育有限：儘管肠内餵食配方在患者护理中发挥关键作用，但医疗保健专业人员、患者和护理人员的意识和教育往往有限。这种认知的缺乏可能导致使用不当、剂量不正确和营养支持不足。医疗保健专业人员可能没有接受过充分的培训，无法根据特定患者的需求开出正确的配方。加强教育和宣传工作对于确保正确使用这些产品和改善患者治疗效果至关重要。
  • 5.竞争与创新：肠内餵食配方奶粉市场竞争激烈，许多厂商争夺市场份额。这种竞争可以推动创新，但也带来挑战。由于製造商努力使自己与众不同，因此存在推出没有足够临床证据或研究支持其主张的产品的风险。平衡创新与严格的科学验证对于维护病人安全和市场诚信至关重要。

主要市场趋势：

  • 1.技术进步：肠内餵食配方领域的技术进步彻底改变了产品开发和管理方法。创新使得高度专业化和营养先进的肠内餵食配方的诞生成为可能，旨在满足患有各种疾病的患者的特定营养需求。精确的配方和生物活性成分的加入有助于患者更好的康復和整体健康。包括可编程帮浦在内的尖端输送系统可确保精确的营养输送，减少併发症。物联网 (IoT) 技术催生了智慧餵食帮浦和监控设备，可传输即时患者资料，从而增强临床决策。人工智慧 (AI) 和机器学习演算法根据患者资料推荐客製化的餵食配方和时间表。
  • 2.细分市场洞察 - 产品：2022 年，标准配方奶粉细分市场占据主导地位，预计将继续扩大。标准肠内餵食配方奶粉的配製是为了满足广大患者的一般营养需求，遵循既定的营养指南，并提供适合大多数患者的常量营养素和微量营养素的均衡组合，没有特定的饮食限製或医疗条件。支持其安全性和有效性的临床证据使它们成为医疗保健提供者的首选。
  • 3.细分市场洞察 - 流量类型：2022 年，间歇餵料流量细分市场占据主导地位，预计将继续扩大。间歇餵食涉及在一天中的特定时段提供营养，使患者可以有更长的时间不使用饲管。与连续餵食相比，这可以提高患者的舒适度和耐受性，提高生活品质并符合自然饮食模式。

区域洞察 - 北美：北美人口的老年人口正在显着增加。由于与年龄相关的健康问题，老年人通常更有可能需要肠内营养。这种需求促进了肠道的成长

目录

第 1 章：产品概述

  • 市场定义
  • 市场范围
    • 涵盖的市场
    • 考虑学习的年份
    • 主要市场区隔

第 2 章：研究方法

  • 研究目的
  • 基线方法
  • 主要产业伙伴
  • 主要协会和二手资料来源
  • 预测方法
  • 数据三角测量与验证
  • 假设和限制

第 3 章：执行摘要

  • 市场概况
  • 主要市场细分概述
  • 主要市场参与者概述
  • 重点地区/国家概况
  • 市场驱动因素、挑战、趋势概述

第 4 章：客户之声

第 5 章：全球肠内餵食配方奶粉市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 副产品（标准配方、特定疾病配方）
    • 依流量类型（间歇给料流、连续给料流）
    • 依阶段（成人、儿童）
    • 依适应症（阿兹海默症、营养缺乏、癌症照护、糖尿病、慢性肾臟病、孤儿疾病、吞嚥困难、疼痛管理、吸收不良/胃肠道疾病/腹泻、其他）
    • 依最终用途（医院、家庭护理）
    • 按地区
    • 按公司划分（前 5 名市场参与者的股份）
  • 市场地图
    • 按产品分类
    • 按流量类型
    • 按阶段
    • 按指示
    • 按最终用途
    • 按地区

第 6 章：北美肠内餵食配方奶粉市场前景

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按产品分类
    • 按流量类型
    • 按阶段
    • 按指示
    • 按最终用途
    • 按国家/地区

第 7 章：欧洲肠内餵食配方奶粉市场前景

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按产品分类
    • 按流量类型
    • 按阶段
    • 按指示
    • 按最终用途
    • 按国家/地区

第 8 章：亚太地区肠内餵食配方奶粉市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按产品分类
    • 按流量类型
    • 按阶段
    • 按指示
    • 按最终用途
    • 按国家/地区

第 9 章：南美洲肠内餵食配方奶粉市场前景

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按类型
    • 按流量类型
    • 按阶段
    • 按指示
    • 按最终用途
    • 按国家/地区

第 10 章：中东和非洲肠内餵食配方奶粉市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按类型
    • 按流量类型
    • 按阶段
    • 按指示
    • 按最终用途
    • 按国家/地区

第 11 章：市场动态

  • 司机
  • 挑战

第 12 章：市场趋势与发展

  • 近期发展
  • 併购
  • 产品发布

第13章：竞争格局

  • 雅培
  • 达能公司
  • 费森尤斯·卡比股份公司
  • 雀巢
  • 维克图斯
  • 普里姆斯製药公司
  • 明治控股。有限公司。
  • 美赞臣公司

第 14 章：策略建议

第 15 章：关于我们与免责声明

简介目录
Product Code: 17206

The Global Enteral Feeding Formulas Market reached a valuation of USD 5.89 Billion in 2022 and is expected to experience steady growth in the forecast period, with a projected Compound Annual Growth Rate (CAGR) of 6.81% and expected to reach USD 8.83 Billion by 2028. The global healthcare industry is undergoing a significant transformation, with a growing emphasis on comprehensive patient care. Nutrition is a critical aspect of patient well-being, and for individuals unable to consume food orally due to medical conditions, enteral feeding formulas have emerged as an essential solution. The Global Enteral Feeding Formulas Market plays a pivotal role in ensuring that individuals, ranging from premature infants to elderly patients, receive the vital nutrients required for recovery and overall health.

Enteral feeding involves delivering nutrients directly into the gastrointestinal tract via a tube. This method is employed when individuals face challenges in oral food consumption due to conditions like swallowing disorders, digestive issues, or critical illness. Enteral feeding formulas, also known as enteral nutrition or tube feeding formulas, are specialized liquid solutions containing a balanced mix of macronutrients, vitamins, and minerals. These formulas are designed to match the specific nutritional needs of different patient groups, spanning from infants to adults. They can be categorized into various types, including standard formulas, disease-specific formulas, and specialized formulations tailored to specific medical conditions such as diabetes or renal failure.

The aging global population is prone to various health conditions that can hinder their ability to eat normally. This has led to an increased demand for enteral feeding formulas customized to the nutritional needs of the elderly. Chronic conditions such as cancer, neurological disorders, and gastrointestinal diseases often affect a patient's capacity to consume solid food. In such cases, enteral feeding formulas provide an effective means of delivering essential nutrients. The market has expanded due to advancements in formula compositions, the development of disease-specific formulas, and innovations in tube-feeding techniques. These developments have made enteral nutrition more viable and effective, thereby contributing to market growth.

Market Overview
Forecast Period2024-2028
Market Size 2022USD 5.89 Billion
Market Size 2028USD 8.83 Billion
CAGR 2023-20286.81%
Fastest Growing SegmentGastrointestinal Diseases
Largest MarketNorth America

Key Market Drivers:

  • 1. Rising Prevalence of Chronic Diseases: Chronic diseases, characterized by their long duration and slow progression, have become a leading cause of morbidity and mortality worldwide. The growing demand for enteral feeding formulas has emerged as a vital component in the management of chronic diseases, driving the expansion of the global enteral feeding formulas market. Lifestyle changes, urbanization, an aging population, and risk factors such as tobacco use, unhealthy diets, physical inactivity, and excessive alcohol consumption have contributed to the surge in chronic diseases. Enteral feeding formulas, also known as tube feeding formulas, are nutritional products designed to provide essential nutrients directly into the gastrointestinal tract for individuals who cannot consume sufficient nutrients orally. These formulas are administered through tubes placed in the stomach or intestines, ensuring that individuals receive the required nutrients to maintain their health and well-being.
  • 2. Increasing Aging Population: As the world's population continues to age, with a growing proportion of elderly individuals, the global healthcare industry is facing new challenges and opportunities. One of the key areas impacted by this demographic shift is the enteral feeding formulas market. Enteral feeding, which involves providing nutrition directly into the digestive system, has become crucial for the well-being of elderly individuals who may struggle with proper nutrition intake due to various health conditions. This has led to the rise of the global enteral feeding formulas market, a sector that is rapidly expanding to meet the needs of an aging population.

Key Market Challenges:

  • 1. Regulatory Hurdles: One of the primary challenges confronting the enteral feeding formulas market is the complex regulatory landscape. Different countries have varying regulations and standards governing the production, labeling, and marketing of these products. Manufacturers must navigate a maze of regulations to ensure their products comply with local laws while also meeting global quality standards. This not only increases operational complexity but also poses a barrier for new entrants looking to establish themselves in the market.
  • 2. Cost Constraints: Enteral feeding formulas are often more expensive than regular food, primarily due to the specialized nature of their composition and production process. The cost can become a significant burden for patients, especially those requiring long-term enteral feeding solutions. Additionally, cost constraints may lead to pricing pressures for manufacturers as healthcare providers and insurers seek cost-effective options. Striking a balance between affordability and quality becomes a significant challenge for both manufacturers and patients.
  • 3. Nutritional Customization: Patients requiring enteral feeding have diverse nutritional needs based on their medical condition, age, and overall health. Developing formulas that can be customized to meet these unique requirements is a challenge. Manufacturers need to invest in research and development to create products that are not only nutritionally balanced but can also be tailored to individual patients. Achieving this level of customization while maintaining production efficiency and cost-effectiveness can be a delicate balancing act.
  • 4. Limited Awareness and Education: Despite the critical role enteral feeding formulas play in patient care, there is often limited awareness and education among healthcare professionals, patients, and caregivers. This lack of awareness can lead to improper usage, incorrect dosing, and inadequate nutritional support. Healthcare professionals may not be adequately trained to prescribe the right formula for specific patient needs. Increasing education and awareness efforts are essential to ensure proper utilization of these products and improve patient outcomes.
  • 5. Competition and Innovation: The enteral feeding formulas market is competitive, with numerous manufacturers vying for market share. This competition can drive innovation, but it also presents challenges. As manufacturers strive to differentiate themselves, there is a risk of introducing products without sufficient clinical evidence or research to support their claims. Balancing innovation with rigorous scientific validation is crucial to maintain patient safety and uphold the integrity of the market.

Key Market Trends:

  • 1. Technological Advancements: Technological advancements in the field of enteral feeding formulas have revolutionized product development and administration methods. Innovations have enabled the creation of highly specialized and nutritionally advanced enteral feeding formulas designed to cater to the specific nutritional requirements of patients with various medical conditions. Precise formulation and the inclusion of bioactive ingredients contribute to better patient recovery and overall health. Cutting-edge delivery systems, including programmable pumps, ensure precise nutrient delivery, reducing complications. Internet of Things (IoT) technology has led to smart feeding pumps and monitoring devices that transmit real-time patient data, enhancing clinical decision-making. Artificial intelligence (AI) and machine learning algorithms recommend tailored feeding formulas and schedules based on patient data.
  • 2. Segmental Insights - Product: In 2022, the Standard Formula segment dominated the market and is predicted to continue expanding. Standard enteral feeding formulas are formulated to meet the general nutritional needs of a wide range of patients, adhering to established nutritional guidelines and offering a balanced combination of macronutrients and micronutrients suitable for most patients without specific dietary restrictions or medical conditions. The availability of clinical evidence supporting their safety and efficacy makes them a preferred choice for healthcare providers.
  • 3. Segmental Insights - Flow Type: In 2022, the Intermittent Feeding Flow segment dominated the market and is predicted to continue expanding. Intermittent feeding involves providing nutrients over specific periods during the day, allowing patients to have longer periods without the feeding tube in use. This can improve patient comfort and tolerance compared to continuous feeding, enhancing quality of life and aligning with natural eating patterns.

Regional Insights - North America: The North American population is experiencing a significant increase in the elderly population. Elderly individuals often have a higher likelihood of requiring enteral nutrition due to age-related health issues. This demand has contributed to the growth of the enteral

feeding formulas market in the region. North America, particularly the United States, possesses a well-developed and sophisticated healthcare infrastructure, ensuring easy access to enteral feeding formulas for patients in need. The region also sees a high prevalence of chronic diseases, further driving demand for these products.

Key Market Players

  • Abbott
  • Danone S.A
  • Fresenius Kabi AG
  • Nestle
  • VICTUS
  • Primus Pharmaceuticals, Inc.
  • Meiji Holdings. Co.,Ltd.
  • Mead Johnson & Company, LLC

Report Scope:

  • In this report, the Global Enteral Feeding Formulas Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Enteral Feeding Formulas Market, By Product:

  • Standard Formula
  • Disease-specific Formulas

Enteral Feeding Formulas Market, By Flow Type:

  • Intermittent Feeding Flow
  • Continuous Feeding Flow

Enteral Feeding Formulas Market, By Stage:

  • Adults
  • Pediatrics

Enteral Feeding Formulas Market, By Indication:

  • Adults
  • Alzheimer's
  • Nutrition Deficiency
  • Cancer Care
  • Diabetes
  • Chronic Kidney Diseases
  • Orphan Diseases
  • Dysphagia, Pain Management
  • Malabsorption/GI Disorder/Diarrhea
  • Others

Enteral Feeding Formulas Market, By End-User:

  • Hospitals
  • Homecare

Enteral Feeding Formulas Market, By Region:

  • North America
  • Asia-Pacific
  • Europe
  • Middle East & Africa
  • South America

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Global Enteral Feeding Formulas Market.

Available Customizations:

  • Global Enteral Feeding Formulas Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Enteral Feeding Formulas Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Standard Formula, Disease-specific Formulas)
    • 5.2.2. By Flow Type (Intermittent Feeding Flow, Continuous Feeding Flow)
    • 5.2.3. By Stage ( Adults, Pediatrics)
    • 5.2.4. By Indication (Alzheimer's, Nutrition Deficiency, Cancer Care, Diabetes, Chronic Kidney Diseases, Orphan Diseases, Dysphagia, Pain Management, Malabsorption/GI Disorder/Diarrhea, Others)
    • 5.2.5. By End-Use (Hospitals, Homecare)
    • 5.2.6. By Region
    • 5.2.7. By Company (Shares of Top 5 Market Players)
  • 5.3. Market Map
    • 5.3.1. By Product
    • 5.3.2. By Flow Type
    • 5.3.3. By Stage
    • 5.3.4. By Indication
    • 5.3.5. By End-Use
    • 5.3.6. By Region

6. North America Enteral Feeding Formulas Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Flow Type
    • 6.2.3. By Stage
    • 6.2.4. By Indication
    • 6.2.5. By End-Use
    • 6.2.6. By Country
      • 6.2.6.1. United States Enteral Feeding Formulas Market Outlook
        • 6.2.6.1.1. Market Size & Forecast
        • 6.2.6.1.1.1. By Value
        • 6.2.6.1.2. Market Share & Forecast
        • 6.2.6.1.2.1. By Product
        • 6.2.6.1.2.2. By Flow Type
        • 6.2.6.1.2.3. By Stage
        • 6.2.6.1.2.4. By Indication
        • 6.2.6.1.2.5. By End-Use
      • 6.2.6.2. Canada Enteral Feeding Formulas Market Outlook
        • 6.2.6.2.1. Market Size & Forecast
        • 6.2.6.2.1.1. By Value
        • 6.2.6.2.2. Market Share & Forecast
        • 6.2.6.2.2.1. By Product
        • 6.2.6.2.2.2. By Flow Type
        • 6.2.6.2.2.3. By Stage
        • 6.2.6.2.2.4. By Indication
        • 6.2.6.2.2.5. By End-Use
      • 6.2.6.3. Mexico Enteral Feeding Formulas Market Outlook
        • 6.2.6.3.1. Market Size & Forecast
        • 6.2.6.3.1.1. By Value
        • 6.2.6.3.2. Market Share & Forecast
        • 6.2.6.3.2.1. By Test
        • 6.2.6.3.2.2. By Flow Type
        • 6.2.6.3.2.3. By Stage
        • 6.2.6.3.2.4. By Indication
        • 6.2.6.3.2.5. By End-Use

7. Europe Enteral Feeding Formulas Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Flow Type
    • 7.2.3. By Stage
    • 7.2.4. By Indication
    • 7.2.5. By End-Use
    • 7.2.6. By Country
      • 7.2.6.1. France Enteral Feeding Formulas Market Outlook
        • 7.2.6.1.1. Market Size & Forecast
        • 7.2.6.1.1.1. By Value
        • 7.2.6.1.2. Market Share & Forecast
        • 7.2.6.1.2.1. By Product
        • 7.2.6.1.2.2. By Flow Type
        • 7.2.6.1.2.3. By Stage
        • 7.2.6.1.2.4. By Indication
        • 7.2.6.1.2.5. By End-Use
      • 7.2.6.2. Germany Enteral Feeding Formulas Market Outlook
        • 7.2.6.2.1. Market Size & Forecast
        • 7.2.6.2.1.1. By Value
        • 7.2.6.2.2. Market Share & Forecast
        • 7.2.6.2.2.1. By Product
        • 7.2.6.2.2.2. By Flow Type
        • 7.2.6.2.2.3. By Stage
        • 7.2.6.2.2.4. By Indication
        • 7.2.6.2.2.5. By End-Use
      • 7.2.6.3. United Kingdom Enteral Feeding Formulas Market Outlook
        • 7.2.6.3.1. Market Size & Forecast
        • 7.2.6.3.1.1. By Value
        • 7.2.6.3.2. Market Share & Forecast
        • 7.2.6.3.2.1. By Product
        • 7.2.6.3.2.2. By Flow Type
        • 7.2.6.3.2.3. By Stage
        • 7.2.6.3.2.4. By Indication
        • 7.2.6.3.2.5. By End-Use
      • 7.2.6.4. Italy Enteral Feeding Formulas Market Outlook
        • 7.2.6.4.1. Market Size & Forecast
        • 7.2.6.4.1.1. By Value
        • 7.2.6.4.2. Market Share & Forecast
        • 7.2.6.4.2.1. By Product
        • 7.2.6.4.2.2. By Flow Type
        • 7.2.6.4.2.3. By Stage
        • 7.2.6.4.2.4. By Indication
        • 7.2.6.4.2.5. By End-Use
      • 7.2.6.5. Spain Enteral Feeding Formulas Market Outlook
        • 7.2.6.5.1. Market Size & Forecast
        • 7.2.6.5.1.1. By Value
        • 7.2.6.5.2. Market Share & Forecast
        • 7.2.6.5.2.1. By Product
        • 7.2.6.5.2.2. By Flow Type
        • 7.2.6.5.2.3. By Stage
        • 7.2.6.5.2.4. By Indication
        • 7.2.6.5.2.5. By End-Use

8. Asia Pacific Enteral Feeding Formulas Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Flow Type
    • 8.2.3. By Stage
    • 8.2.4. By Indication
    • 8.2.5. By End-Use
    • 8.2.6. By Country
      • 8.2.6.1. China Enteral Feeding Formulas Market Outlook
        • 8.2.6.1.1. Market Size & Forecast
        • 8.2.6.1.1.1. By Value
        • 8.2.6.1.2. Market Share & Forecast
        • 8.2.6.1.2.1. By Product
        • 8.2.6.1.2.2. By Flow Type
        • 8.2.6.1.2.3. By Stage
        • 8.2.6.1.2.4. By Indication
        • 8.2.6.1.2.5. By End-Use
      • 8.2.6.2. India Enteral Feeding Formulas Market Outlook
        • 8.2.6.2.1. Market Size & Forecast
        • 8.2.6.2.1.1. By Value
        • 8.2.6.2.2. Market Share & Forecast
        • 8.2.6.2.2.1. By Product
        • 8.2.6.2.2.2. By Flow Type
        • 8.2.6.2.2.3. By Stage
      • 8.2.6.3. South Korea Enteral Feeding Formulas Market Outlook
        • 8.2.6.3.1. Market Size & Forecast
        • 8.2.6.3.1.1. By Value
        • 8.2.6.3.2. Market Share & Forecast
        • 8.2.6.3.2.1. By Product
        • 8.2.6.3.2.2. By Flow Type
        • 8.2.6.3.2.3. By Stage
        • 8.2.6.3.2.4. By Indication
        • 8.2.6.3.2.5. By End-Use
      • 8.2.6.4. Japan Enteral Feeding Formulas Market Outlook
        • 8.2.6.4.1. Market Size & Forecast
        • 8.2.6.4.1.1. By Value
        • 8.2.6.4.2. Market Share & Forecast
        • 8.2.6.4.2.1. By Product
        • 8.2.6.4.2.2. By Flow Type
        • 8.2.6.4.2.3. By Stage
        • 8.2.6.4.2.4. By Indication
        • 8.2.6.4.2.5. By End-Use
      • 8.2.6.5. Australia Enteral Feeding Formulas Market Outlook
        • 8.2.6.5.1. Market Size & Forecast
        • 8.2.6.5.1.1. By Value
        • 8.2.6.5.2. Market Share & Forecast
        • 8.2.6.5.2.1. By Product
        • 8.2.6.5.2.2. By Flow Type
        • 8.2.6.5.2.3. By Stage
        • 8.2.6.5.2.4. By Indication
        • 8.2.6.5.2.5. By End-Use

9. South America Enteral Feeding Formulas Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Flow Type
    • 9.2.3. By Stage
    • 9.2.4. By Indication
    • 9.2.5. By End-Use
    • 9.2.6. By Country
      • 9.2.6.1. Brazil Enteral Feeding Formulas Market Outlook
        • 9.2.6.1.1. Market Size & Forecast
        • 9.2.6.1.1.1. By Value
        • 9.2.6.1.2. Market Share & Forecast
        • 9.2.6.1.2.1. By Product
        • 9.2.6.1.2.2. By Flow Type
        • 9.2.6.1.2.3. By Stage
      • 9.2.6.2. Argentina Enteral Feeding Formulas Market Outlook
        • 9.2.6.2.1. Market Size & Forecast
        • 9.2.6.2.1.1. By Value
        • 9.2.6.2.2. Market Share & Forecast
        • 9.2.6.2.2.1. By Product
        • 9.2.6.2.2.2. By Flow Type
        • 9.2.6.2.2.3. By Stage
        • 9.2.6.2.2.4. By Indication
        • 9.2.6.2.2.5. By End-Use
      • 9.2.6.3. Colombia Enteral Feeding Formulas Market Outlook
        • 9.2.6.3.1. Market Size & Forecast
        • 9.2.6.3.1.1. By Value
        • 9.2.6.3.2. Market Share & Forecast
        • 9.2.6.3.2.1. By Product
        • 9.2.6.3.2.2. By Flow Type
        • 9.2.6.3.2.3. By Stage
        • 9.2.6.3.2.4. By Indication
        • 9.2.6.3.2.5. By End-Use

10. Middle East & Africa Enteral Feeding Formulas Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Flow Type
    • 10.2.3. By Stage
    • 10.2.4. By Indication
    • 10.2.5. By End-Use
    • 10.2.6. By Country
      • 10.2.6.1. South Africa Enteral Feeding Formulas Market Outlook
        • 10.2.6.1.1. Market Size & Forecast
        • 10.2.6.1.1.1. By Value
        • 10.2.6.1.2. Market Share & Forecast
        • 10.2.6.1.2.1. By Product
        • 10.2.6.1.2.2. By Flow Type
        • 10.2.6.1.2.3. By Stage
      • 10.2.6.2. Saudi Arabia Enteral Feeding Formulas Market Outlook
        • 10.2.6.2.1. Market Size & Forecast
        • 10.2.6.2.1.1. By Value
        • 10.2.6.2.2. Market Share & Forecast
        • 10.2.6.2.2.1. By Product
        • 10.2.6.2.2.2. By Flow Type
        • 10.2.6.2.2.3. By Stage
        • 10.2.6.2.2.4. By Indication
        • 10.2.6.2.2.5. By End-Use
      • 10.2.6.3. UAE Enteral Feeding Formulas Market Outlook
        • 10.2.6.3.1. Market Size & Forecast
        • 10.2.6.3.1.1. By Value
        • 10.2.6.3.2. Market Share & Forecast
        • 10.2.6.3.2.1. By Product
        • 10.2.6.3.2.2. By Flow Type
        • 10.2.6.3.2.3. By Stage
        • 10.2.6.3.2.4. By Indication
        • 10.2.6.3.2.5. By End-Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Competitive Landscape

  • 13.1. Abbott
  • 13.2. Danone S.A
  • 13.3. Fresenius Kabi AG
  • 13.4. Nestle
  • 13.5. VICTUS
  • 13.6. Primus Pharmaceuticals, Inc.
  • 13.7. Meiji Holdings. Co.,Ltd.
  • 13.8. Mead Johnson & Company, LLC

14. Strategic Recommendations

15. About us & Disclaimer